Rapid Micro Biosystems (RPID) Accounts Payables (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Accounts Payables data on file, last reported at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 77.23% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (up 77.23% YoY), and the FY2025 full-year result was $4.1 million, up 63.27% from the prior year.
• Accounts Payables improved to $4.7 million in Q1 2026, from $4.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $5.4 million in Q4 2022 to a low of $1.2 million in Q1 2024.
• A 5-year average of $2.9 million and a median of $2.8 million in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables sank 63.75% in 2023 and surged 126.37% in 2025, its largest moves.
• Tracing RPID's Accounts Payables over 5 years: stood at $5.4 million in 2022, then plunged by 63.65% to $2.0 million in 2023, then gained by 28.48% to $2.5 million in 2024, then jumped by 63.27% to $4.1 million in 2025, then grew by 12.83% to $4.7 million in 2026.
• Business Quant data shows RPID's Accounts Payables at $4.7 million in Q1 2026, $4.1 million in Q4 2025, and $3.6 million in Q3 2025.